Analysis of Clinical Manifestations and Prognostic Factors Affecting Osteosarcoma

Abstract

Objective. This study is aimed at exploring the clinical manifestations and prognostic factors of osteosarcoma. Methods. The clinical data of patients with osteosarcoma who were treated in our hospital from January 2018 to March 2020 were selected for retrospective analysis. The general information of the patients, including age, gender, tumor diameter, tumor location, tumor type, surgical method, and Enneking stage, distant disease metastasis, KPS score, and the number of postoperative adjuvant chemotherapy, were grouped by prognosis for statistical analysis. The clinical characteristics, morbidity and mortality, and prognostic factors of patients were statistically analyzed. Results. Among the 83 patients in this group, there were 52 males and 31 females, $59\text{tumors}>10\text{cm}$ in diameter and $24\text{tumors}<10\text{cm}$ in diameter, 16 tumors in the upper limbs and 67 tumors in the lower limbs, 25 tumors in osteoblastoma, 16 tumors in chondroblastoma, 42 tumors in fibroblastoma, 62 tumors in stage II, and 21 tumors in stage III of Enneking stage, 10 tumors in distant metastasis, and 10 tumors in distant metastasis. The death rate of this group was 19.28% (16/83). Multifactor regression analysis confirmed that the Enneking stage III, distant metastasis, $\text{KPS}\text{score}<70$ , and the number of $\text{postoperative}\text{adjuvant}\text{chemotherapy}<6$ were important factors influencing the death of osteosarcoma ( $P<0.05$ ). Conclusion. Enneking stage III, distant metastasis, $\text{KPS}\text{score}<70$ , and the number of $\text{postoperative}\text{adjuvant}\text{chemotherapy}<6$ are important influencing factors of osteosarcoma death. Clinical practice can take corresponding preventive and control measures according to the existence of these factors to ensure a good prognosis.